Pharmaceutical News

RSS

Study highlights importance of independent evaluation of Tamiflu drug

Tom Jefferson and colleagues from the Cochrane Group argue that the current system for assessing the safety and effectiveness of drugs, based on published trial data only, is "wholly inadequate" and "ethically dubious."

12 Jan 2011

Study shows delivering cancer drug in hydrophobic nanoparticle is a safe and effective prostate cancer therapy

Researchers at MIT and Brigham and Women's Hospital have shown that they can deliver the cancer drug cisplatin much more effectively and safely in a form that has been encapsulated in a nanoparticle targeted to prostate tumor cells and is activated once it reaches its target.

12 Jan 2011

New research identifies nutrition inadequacy among Americans

At a time when the country is facing an obesity epidemic, the problem of nutrition inadequacy is often overlooked. Yet, many Americans are overweight and undernourished, concludes a new study called "What America's Missing."

12 Jan 2011

Study: 23% of doctors have negative perceptions on quality, effectiveness of generic drugs

A new study by researchers at Harvard, Brigham and Women's Hospital and CVS Caremark finds that 23 percent of doctors' have negative perceptions of the effectiveness and quality of generic drugs and that may lead to doctors prescribing unnecessarily expensive medications.

12 Jan 2011

56% of respondents have still not received flu shots

As we enter peak flu season, flu activity is steadily increasing in the United States, with eight states now reporting widespread outbreaks of influenza cases according to the most recent Centers for Disease Control and Prevention (CDC) report.

12 Jan 2011

Apixaban drug raises hope for DVT prevention in patients undergoing hip replacement surgery

A worldwide research consortium that includes the University of Oklahoma Health Sciences Center has proven that a new drug is more effective and easier to use than current medicines in the prevention of blood clots following hip replacement surgery.

12 Jan 2011

Herpes zoster vaccine reduces risk of developing shingles by 55%

Receiving the herpes zoster vaccine was associated with a 55 percent reduced risk of developing shingles, according to a Kaiser Permanente study of 300,000 people that appears in the current issue of the Journal of the American Medical Association.

12 Jan 2011

Coventry Health Care offers new medicare plans for employer group

Coventry Health Care of Florida is first to the greater Tampa market with a portfolio of hybrid PPO health care plans that blend the best features of traditional co-pay based plans with the freedom and affordability of consumer-directed plans.

12 Jan 2011

BPH, hair loss prevention drugs may produce adverse side effects in men

Researchers from Boston University School of Medicine, in collaboration with colleagues at Lahey Clinic and from Denmark and Germany, have found that 5a-reductase inhibitors, while improving urinary symptoms in patients with benign prostatic hyperplasia and possible hair loss prevention, produces significant adverse effects in some individuals including loss of libido, erectile dysfunction, ejaculatory dysfunction and potential depression.

12 Jan 2011

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Merck today announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S. Food and Drug Administration (FDA). The Company is also moving forward as planned with regulatory filings in countries outside the United States.

12 Jan 2011

Patients who consume painkillers may face cardiovascular risk

The drugs include traditional non-steroidal anti-inflammatory drugs as well as new generation anti-inflammatory drugs, known as COX-2 inhibitors. The researchers say that doctors and patients need to be aware that prescription of any anti-inflammatory drug needs to take cardiovascular risk into account.

12 Jan 2011

Zogenix, Desitin receive MAA approval for SUMAVEL DosePro in Germany and the UK

Aradigm Corporation today announced that Zogenix, Inc. and Desitin Pharmaceuticals GmbH were granted approval of the Marketing Authorization Application for SUMAVEL® DosePro™ (sumatriptan injection) needle-free delivery system for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache by the Federal Institute for Drugs and Medical Devices of Germany (BrArM) and the Medicines and Healthcare products Regulatory Agency of the United Kingdom (MHRA).

11 Jan 2011

ESHRE Annual Meeting addresses latest breakthroughs in reproductive medicine

Reproductive medicine is one of today's most exciting scientific and clinical areas. Every month there are announcements of medical 'firsts', new rulings by regulatory bodies or ethical controversies. These often spark a heated debate among practitioners in the field, ethicists, legislators, the media and the public. ESHRE's Annual Meeting is the forum where more than 9,000 of the world's leading experts in reproductive medicine gather to give a public presentation of their latest research findings.

11 Jan 2011

Genzyme provides update on discussions with Sanofi-Aventis

Genzyme Corp. (NASDAQ: GENZ) reported today that discussions between its financial advisors and financial advisors for Sanofi-Aventis are continuing and have expanded to include representatives of both companies.

11 Jan 2011

Study to identify early warning biomarkers for presence of breast and prostate cancers

Using biological samples taken from patients and state-of-the-art biochemical techniques, a Florida State University researcher is working to identify a variety of "biomarkers" that might provide earlier warnings of the presence of breast and prostate cancers.

11 Jan 2011

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant, is providing an update regarding its efforts to file a Complete Response intended to gain U.S. Food and Drug Administration (FDA) marketing authorization of Surfaxin® for the prevention of respiratory distress syndrome (RDS) in premature infants.

11 Jan 2011

Largest, national long-term study of children's health opens for Cuyahoga County

Residents of Cuyahoga County, and later Lorain County, will soon have the opportunity to contribute to the establishment of a national resource for childhood growth and development. The National Children's Study is the largest, long-term study of children's health ever conducted in the United States. It will follow 100,000 children from pre-birth to 21-years-old. The study will enroll women who are pregnant or planning to become pregnant in the next few years.

11 Jan 2011

Nutriceuticals may restore age-related vision loss

While age-related vision loss of catastrophic proportions is predicted in coming decades, rising from 17 million patients today to 55 million by the year 2050, it's possible this catastrophe could be averted and lost vision even restored using molecular medicine.

11 Jan 2011

Predator microbes may work against antibiotic resistant disease-causing bacteria: Study

There are predators in the bacterial world that consume other bacteria, much as predators attack prey in the animal world. A team led by researchers at the University of Medicine and Dentistry of New Jersey-New Jersey Dental School suggests that some of these predator microbes might be put to work against disease-causing bacteria that have become resistant to antibiotics.

11 Jan 2011

PPD announces joint venture with TBL to develop novel biotherapeutics

PPD, today announced it has established a joint venture with Taijitu Biologics Limited in the area of the discovery of novel biotherapeutics. The joint venture, named BioDuro Biologics, expands PPD's capability to deliver unique, highly differentiated drug discovery services for biopharmaceutical companies across the globe.

10 Jan 2011

Pharmaceutical News

Study highlights importance of independent evaluation of Tamiflu drug

Study shows delivering cancer drug in hydrophobic nanoparticle is a safe and effective prostate cancer therapy

New research identifies nutrition inadequacy among Americans

Study: 23% of doctors have negative perceptions on quality, effectiveness of generic drugs

56% of respondents have still not received flu shots

Apixaban drug raises hope for DVT prevention in patients undergoing hip replacement surgery

Herpes zoster vaccine reduces risk of developing shingles by 55%

Coventry Health Care offers new medicare plans for employer group

BPH, hair loss prevention drugs may produce adverse side effects in men

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Patients who consume painkillers may face cardiovascular risk

Zogenix, Desitin receive MAA approval for SUMAVEL DosePro in Germany and the UK

ESHRE Annual Meeting addresses latest breakthroughs in reproductive medicine

Genzyme provides update on discussions with Sanofi-Aventis

Study to identify early warning biomarkers for presence of breast and prostate cancers

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

Largest, national long-term study of children's health opens for Cuyahoga County

Nutriceuticals may restore age-related vision loss

Predator microbes may work against antibiotic resistant disease-causing bacteria: Study

PPD announces joint venture with TBL to develop novel biotherapeutics

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News